D(T)PACE as salvage therapy for aggressive or refractory multiple myeloma-Reference-Cited by-同舟云学术

D(T)PACE as salvage therapy for aggressive or refractory multiple myeloma

Published:2013-04-18 Issue:6 Volume:161 Page:802-810
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Gerrie Alina S.¹,Mikhael Joseph R.²,Cheng Lu³,Jiang Haiyan³,Kukreti Vishal⁴,Panzarella Tony³,Reece Donna⁴,Stewart Keith A.²,Trieu Young⁴,Trudel Suzanne⁴,Chen Christine I.⁴

Affiliation:

1. Hematology; University of British Columbia; Vancouver; BC; Canada

2. Department of Hematology/Oncology; Mayo Clinic Arizona; Scottsdale; AZ; USA

3. Division of Biostatistics; Princess Margaret Hospital; Toronto; ON; Canada

4. Department of Medical Oncology and Hematology; Princess Margaret Hospital; Toronto; ON; Canada

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12325/fullpdf

Reference20 articles.

1. Thalidomide and hematopoietic-cell transplantation for multiple myeloma;Barlogie;New England Journal of Medicine,2006

2. Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3;Barlogie;British Journal of Haematology,2007

3. Covariance analysis of heart transplant survival data;Crowley;Journal of the American Statistical Association,1977

4. Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients;Dadacaridou;Journal of BUON,2007

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A single‐day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies;European Journal of Haematology;2024-07-02

2. A Clinical Perspective on Plasma Cell Leukemia: A Single-Center Experience;Cancers;2024-06-05

3. An overview of multiple myeloma: A monoclonal plasma cell malignancy’s diagnosis, management, and treatment modalities;Saudi Journal of Biological Sciences;2024-02

4. Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies;Annals of Hematology;2023-09-05

5. Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice;Cancers;2023-04-05